Kai Wohlfarth

2.4k total citations
45 papers, 1.8k citations indexed

About

Kai Wohlfarth is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Kai Wohlfarth has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 17 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Kai Wohlfarth's work include Botulinum Toxin and Related Neurological Disorders (19 papers), Neurological disorders and treatments (19 papers) and Hereditary Neurological Disorders (10 papers). Kai Wohlfarth is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (19 papers), Neurological disorders and treatments (19 papers) and Hereditary Neurological Disorders (10 papers). Kai Wohlfarth collaborates with scholars based in Germany, Austria and Sweden. Kai Wohlfarth's co-authors include Reinhard Dengler, Hans Bigalke, Robert L. Macdonald, Matt T. Bianchi, Jürgen Frevert, Florian Wegner, Margot Schubert, Jens D. Rollnik, Wilhelm Schulte‐Mattler and Andon Kossev and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Kai Wohlfarth

43 papers receiving 1.7k citations

Peers

Kai Wohlfarth

NEURO

CMN

PHYSI

PMH

Vincenzo Provitera Italy

Timothy L. Williams United Kingdom

Peter Heywood United Kingdom

Jennifer L. Tillerson United States

Sharon Hassin‐Baer Israel

Bo Johnels Sweden

Johannes H.T.M. Koelman Netherlands

Bülent Elibol Türkiye

Lucy Norcliffe‐Kaufmann United States

A. Perretti Italy

Vincenzo Provitera Italy

Kai Wohlfarth

1.1k ×1.1

NEURO

626 ×0.8

CMN

675 ×2.1

PHYSI

200 ×0.8

152 ×0.8

PMH

Citations per year, relative to Kai Wohlfarth Kai Wohlfarth (= 1×) peers Vincenzo Provitera

Countries citing papers authored by Kai Wohlfarth

Since Specialization

Citations

This map shows the geographic impact of Kai Wohlfarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Wohlfarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Wohlfarth more than expected).

Fields of papers citing papers by Kai Wohlfarth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Wohlfarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Wohlfarth. The network helps show where Kai Wohlfarth may publish in the future.

Co-authorship network of co-authors of Kai Wohlfarth

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Wohlfarth. A scholar is included among the top collaborators of Kai Wohlfarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Wohlfarth. Kai Wohlfarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niederstraßer, Olaf, et al.. (2024). Rare intravascular large B-cell lymphoma (IVLBCL) can cause atypical intracerebral haemorrhage and mislead diagnostics. BMJ Case Reports. 17(9). e260498–e260498.

Wohlfarth, Kai, et al.. (2020). Isolated Bilateral Internal Carotid Artery Stenosis and Recurrent Ischemic Strokes in a Patient with Suspected Giant Cell Arteritis. SHILAP Revista de lepidopterología. 12(1). 84–91. 5 indexed citations

Kutschenko, Anna, Hans Bigalke, Florian Wegner, & Kai Wohlfarth. (2019). The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products. Toxicon. 168. 158–163. 12 indexed citations

Kutschenko, Anna, Jasmin Weisemann, Katja Kollewe, et al.. (2019). Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients. Clinical Neurophysiology. 130(6). 1066–1073. 9 indexed citations

Schwenkreis, Peter, et al.. (2018). Qualitätsstandards in der Behandlung und Rehabilitation von Schädel-Hirn-Verletzungen. Der Chirurg. 89(12). 1017–1032. 1 indexed citations

Lange, Oliver, et al.. (2009). Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A. Clinical Neuropharmacology. 32(4). 213–218. 107 indexed citations

Wohlfarth, Kai, Florian Wegner, Tim Jürgens, et al.. (2008). Biological activity of two botulinum toxin type A complexes (Dysport® and Botox®) in volunteers. Journal of Neurology. 255(12). 1932–1939. 58 indexed citations

Wohlfarth, Kai, Christian Müller, Irena Sassin, Georg Comes, & Susanne Grafe. (2007). Neurophysiological Double-Blind Trial of a Botulinum Neurotoxin Type A Free of Complexing Proteins. Clinical Neuropharmacology. 30(2). 86–94. 56 indexed citations

Wegner, Florian, et al.. (2006). Auto-modulation of neuroactive steroids on GABAA receptors: A novel pharmacological effect. Neuropharmacology. 52(2). 672–683. 14 indexed citations

10.

Wohlfarth, Kai, Knut Kampe, & Hans Bigalke. (2004). Pharmacokinetic properties of different formulations of botulinum neurotoxin type A. Movement Disorders. 19(S8). S65–S67. 29 indexed citations

11.

Bigalke, Hans, et al.. (2001). Botulinum A Toxin: Dysport Improvement of Biological Availability. Experimental Neurology. 168(1). 162–170. 43 indexed citations

12.

Rollnik, Jens D., Mike Matzke, Kai Wohlfarth, Reinhard Dengler, & Hans Bigalke. (2000). Low-Dose Treatment of Cervical Dystonia, Blepharospasm and Facial Hemispasm with Albumin-Diluted Botulinum Toxin Type A under EMG Guidance. European Neurology. 43(1). 9–12. 35 indexed citations

13.

Rollnik, Jens D., et al.. (2000). Effects of somatosensory input on central fatigue: a pilot study. Clinical Neurophysiology. 111(10). 1843–1846. 10 indexed citations

14.

Wohlfarth, Kai, Udo Schneider, Margot Schubert, et al.. (2000). Acamprosate Reduces Motor Cortex Excitability Determined by Transcranial Magnetic Stimulation. Neuropsychobiology. 42(4). 183–186. 12 indexed citations

15.

Schubert, Margot, Kai Wohlfarth, Jens D. Rollnik, & Reinhard Dengler. (1998). Walking and fatigue in multiple sclerosis: The role of the corticospinal system. Muscle & Nerve. 21(8). 1068–1070. 52 indexed citations

16.

Wohlfarth, Kai, et al.. (1998). Supraglottal Injection of Botulinum Toxin Type A in Adductor Type Spasmodic Dysphonia With Both Intrinsic and Extrinsic Hyperfunction. The Laryngoscope. 108(1). 55–63. 36 indexed citations

17.

Wohlfarth, Kai, et al.. (1997). Botulinum A toxins: units versus units. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(3). 335–340. 88 indexed citations

18.

Wohlfarth, Kai, et al.. (1997). Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences. Experimental Neurology. 147(1). 96–102. 249 indexed citations

19.

Dengler, Reinhard, et al.. (1996). Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia. Muscle & Nerve. 19(4). 456–462. 28 indexed citations

20.

Schubert, Margot, et al.. (1993). Activation of high-threshold motor units in man by transcranial magnetic stimulation. Neuroscience Letters. 150(1). 21–24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact